May 01, 2018 12:01 pm UTC| Business
GREENWICH, Conn., May 01, 2018 -- Oxford Square Capital Corp. (NasdaqGS:OXSQ) (“OXSQ,” the “Company,” “we,” “us” or “our”) announced today its financial results for the quarter ended March 31, 2018, and announced a...
Cosmos Holdings, Inc. Releases Its New Nutraceutical Brand
May 01, 2018 12:01 pm UTC| Business
CHICAGO, May 01, 2018 -- Cosmos Holdings, Inc. (OTCQB:COSM), released the design and packaging of its first set of dietary supplements. These premium supplements boast a sleek design and packaging along with best in...
Seaborn Selects C+L Band Design for ARBR to Serve the Needs of the ICP Community
May 01, 2018 12:01 pm UTC| Business
ALLEN, Texas and DALLAS, May 01, 2018 -- Xtera®, the system supplier for the ARBR project, announces today that Seaborn Networks (“Seaborn”), a leading developer-owner-operator of submarine fiber optic cable systems,...
Varonis to Present at May Investor Conferences
May 01, 2018 12:01 pm UTC| Business
NEW YORK, May 01, 2018 -- Varonis Systems, Inc. (NASDAQ:VRNS), a pioneer in data security and analytics, today announced its participation at the following upcoming conferences: The Jefferies 2018 Technology...
TellerScan TS500 Scanner Certified for Acuant ID Verification Platform
May 01, 2018 12:01 pm UTC| Business
Northbrook, IL, May 01, 2018 -- Digital Check’s TellerScan TS500 check scanner has been certified by Acuant Corp. for both its AssureID Document Authentication and ID Verification software and its AcuFill Intelligent...
eSilicon deep learning ASIC in production qualification
May 01, 2018 12:01 pm UTC| Business
Chip employs TSMC CoWoS® technology to integrate SoC and HBM2 SAN JOSE, Calif., May 01, 2018 -- eSilicon, an independent provider of FinFET-class ASICs, custom IP, and advanced 2.5D packaging solutions, today...
VBL Therapeutics to Report First Quarter 2018 Financial Results on May 17
May 01, 2018 12:01 pm UTC| Business
TEL AVIV, Israel, May 01, 2018 -- VBL Therapeutics (Nasdaq:VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for cancer, today...